Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP370508.RAftL8I1A3gedPc9h8HsOqljIiJr_EJkyeiAl3L8vZ228130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370508.RAftL8I1A3gedPc9h8HsOqljIiJr_EJkyeiAl3L8vZ228130_provenance.
• NP203526.RAh9pV36-q5rP5lMKqJh2rRiEVdAloNoaPtAEMCB3KluQ130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203526.RAh9pV36-q5rP5lMKqJh2rRiEVdAloNoaPtAEMCB3KluQ130_provenance.
• NP673033.RAdaqTKTMBfeb-UWO7XMcdflLH2ZGM3ypbhLXYSaZayQ8130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673033.RAdaqTKTMBfeb-UWO7XMcdflLH2ZGM3ypbhLXYSaZayQ8130_provenance.
• NP355061.RAl-f7XlEM0E2P_AAONzevbjWat4oyNX-CFFCzVxOwUsE130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP355061.RAl-f7XlEM0E2P_AAONzevbjWat4oyNX-CFFCzVxOwUsE130_provenance.
• NP638351.RApetlpkeJePTUr0YpPOlfdPWFm14cqpmhhgGYog1m9-I130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638351.RApetlpkeJePTUr0YpPOlfdPWFm14cqpmhhgGYog1m9-I130_provenance.
• NP760618.RAk1HBQoAG0lfIm0WOMaDNvMlfWVUOnkbT4-qedeGbOIQ130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP760618.RAk1HBQoAG0lfIm0WOMaDNvMlfWVUOnkbT4-qedeGbOIQ130_provenance.
• NP428934.RAHze4AI43UbZqqQsNktExJm0YL4rzusu9Z28UYeYlLZ0130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428934.RAHze4AI43UbZqqQsNktExJm0YL4rzusu9Z28UYeYlLZ0130_provenance.
• NP489746.RALLkeprj5VKSbLnpHClhKS2neM4Z1T5XtQYHS8WSfz6E130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP489746.RALLkeprj5VKSbLnpHClhKS2neM4Z1T5XtQYHS8WSfz6E130_provenance.
• NP862440.RACcA_Re3JJUtfghnoX1nriX6Kjyl2m2hXqLYAl7GGNXo130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862440.RACcA_Re3JJUtfghnoX1nriX6Kjyl2m2hXqLYAl7GGNXo130_provenance.
• NP708813.RA3NhMkkNhnY86d9ZelvrHQyci0LJeNFCIdxmBECX_pVw130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708813.RA3NhMkkNhnY86d9ZelvrHQyci0LJeNFCIdxmBECX_pVw130_provenance.
• NP803133.RARAPgbMvDh6GathZwI4IHFE2eUSBNJ_ogVukup84fkQE130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803133.RARAPgbMvDh6GathZwI4IHFE2eUSBNJ_ogVukup84fkQE130_provenance.
• NP862444.RAws3Nk2n5_JH_v3nUw-EgYmBUBBnY9E-hApJy2R-eAQw130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862444.RAws3Nk2n5_JH_v3nUw-EgYmBUBBnY9E-hApJy2R-eAQw130_provenance.
• NP306401.RAHiJt4vCqrlKI0KBMbjtV0uTb_nwnn0N7gSdTzJm5sHQ130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306401.RAHiJt4vCqrlKI0KBMbjtV0uTb_nwnn0N7gSdTzJm5sHQ130_provenance.
• NP554408.RAHrGzukhMLRWZCOkjvLr6aHiIqJOdYR_XiXKRSc5ilAA130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554408.RAHrGzukhMLRWZCOkjvLr6aHiIqJOdYR_XiXKRSc5ilAA130_provenance.
• NP862442.RAZ0bEJe-kWBcW-BKXL8WOph7l47ZwoJmXgWSeU5eyZYQ130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862442.RAZ0bEJe-kWBcW-BKXL8WOph7l47ZwoJmXgWSeU5eyZYQ130_provenance.
• NP862443.RAt4_YlfIvjufVczPycrrGm0-XEpoOpOGBnTQH5SE04ig130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862443.RAt4_YlfIvjufVczPycrrGm0-XEpoOpOGBnTQH5SE04ig130_provenance.
• NP862445.RAL9Zq4w59IkxPy-QgGRweODHVHpSmUpul2l7KiFKjKKY130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862445.RAL9Zq4w59IkxPy-QgGRweODHVHpSmUpul2l7KiFKjKKY130_provenance.
• NP946076.RAE6L3ZgPfoRjTaUj4h8BNhQydcGWHeUq2BSVZiI6nw08130_assertion description "[There is also no defined molecular signature for MPNST development, although several cell-cycle and signalling regulation genes (CDKN2A, TP53, RB1, EGFR, CD44, PDGFR, PDGFRA, HGF, MET and SOX9) are deregulated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946076.RAE6L3ZgPfoRjTaUj4h8BNhQydcGWHeUq2BSVZiI6nw08130_provenance.